MARKETWISE, INC. Stock Compensation Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Cost of revenue | $ | 2,877 | $ | 2,922 | $ | 1,972 | |||||||||||
| Sales and marketing | 2,814 | 3,185 | 2,209 | ||||||||||||||
| General and administrative | 6,511 | 17,277 | 4,864 | ||||||||||||||
| Total stock-based compensation expense | $ | 12,202 | $ | 23,384 | $ | 9,045 | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| 2021 Incentive Award Plan | $ | 9,897 | $ | 22,297 | $ | 8,608 | |||||||||||
| Employee Stock Purchase Plan | 240 | 341 | 437 | ||||||||||||||
| Profits interests | 2,065 | 746 | — | ||||||||||||||
| Total stock-based compensation expense | $ | 12,202 | $ | 23,384 | $ | 9,045 | |||||||||||
| RSUs | SARs | ||||||||||||||||||||||
| Units | Weighted-Average Grant Date Fair Value | Units | Weighted-Average Grant Date Fair Value | ||||||||||||||||||||
Outstanding at January 1, 2024 | 7,740,261 | $ | 2.57 | 1,586,184 | $ | 4.05 | |||||||||||||||||
| Granted | 23,330,718 | 1.07 | — | — | |||||||||||||||||||
| Vested (RSUs) or Exercised (SARs) | (2,486,652) | 2.83 | — | — | |||||||||||||||||||
| Forfeited | (3,180,883) | 1.69 | (365,869) | 4.05 | |||||||||||||||||||
Outstanding at December 31, 2024 | 25,403,444 | $ | 1.28 | 1,220,315 | $ | 4.05 | |||||||||||||||||
Exercisable at December 31, 2024 | — | $ | — | 929,652 | $ | 4.05 | |||||||||||||||||
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.